Enrique Castellón Leal

Cross Road Biotech Inversiones Biotecnologicas SGEIC SA (Cross Road Biotech Inversiones Biotecnologicas) is a venture capital firm founded in 2001 by Enrique Castellon Leal. The firm is headquartered in Madrid, Spain.

Metabolic Renal Disease SL develops mass-spectrometry based tools for targeted metabolomics. It is a biotechnology company that specializes in the field of biometrics. The company's activity is centered in the development of analytical tools based in mass spectrometry and oriented to metabolomics for the identification, quantification and interpretation of metabolites in biofluids. The firm offers a range of applications, specially related to toxicology and pharmacological evaluation. Metabolic Renal Disease was founded in 2008 and is headquartered in San Sebastian, Spain.

Dendrico SL is a holding company engaged in the development and manufacture of nanotechnology systems. These find applications in the fields of diagnostics, therapeutics, and medical research. The company was founded in 2005 and is headquartered in Madrid, Spain.

Inter-American Development Bank engages in the provision of development financing to the Latin American and the Caribbean region. Its activities include provision of loans, grants, and technical assistance; and conducts extensive research. It provides services to the central governments, provinces, municipalities, private firms, and non-governmental organizations. The company was founded in 1959 and is headquartered in Washington, DC.

Traslational Cancer Drugs Pharma SL engages in the discovery and development of therapeutic solutions for the treatment of cancer. Its TCD-717 choline kinase alpha inhibitor is an intravenously-administered small molecule designed to target cancer cells. It also provides technology in-licensing and out-licensing services. The company was founded by Juan Carlos San Juan on July 29, 2005 and is headquartered in Valladolid, Spain.

Health in Code SL specializes in the genetic diagnosis of cardiovascular diseases. The firm provides gene panel testing and interpretation services for a variety of cardiopathies, including pulmonary hypertension, hypercholesterolemia and ventricular tachycardia. Its services include Medical Genetics, Laboratory Management System, HiC-Mutations and Laboratory Services. The company was founded by Lorenzo Jose Montserrat on June 23, 2006 and is headquartered in A Coruna, Spain.